clearmindmedicine.com (CMND): Price to Sales

Symbol and logo of brand Clearmind Medicine, Inc. (CMND)

Clearmind Medicine Inc. relies on Israeli centers to develop psychedelic therapies for addiction treatment. The revenue valuation metric based on GURU.Markets data is illustrated on this chart, where determines the current status of the parameter. A scaling model based on contract synthesis ensures high margins, while outsourcing trials while maintaining full patent control eliminates dependence on external suppliers.

CMND clearmindmedicine.com: Price-to-Revenue Ratio in the range 07/04/2022 - 11/17/2026

Analytical breakdowns for clearmindmedicine.com (CMND)

- share price and consensus valuation forecast:
Fundamental company analysis:clearmindmedicine.com, CMND
Mass-produced product of Clearmind Medicine Inc.

The P/S ratio reflects market capitalization relative to annual sales volume, allowing for a business valuation through the lens of generated revenue. By analyzing the current price-to-sales value, an investor can compare market expectations with the actual commercialization rates of the Clearmind Medicine Inc. (CMND) R&D pipeline for the development of MEAI molecules for alcoholism therapy currently in the preclinical trial stage.